Latest Lead News

Icetana Limited has announced a fully underwritten renounceable entitlement offer to raise approximately $2.65 million, aiming to bolster sales, marketing, and product development efforts. The offer, priced at $0.02 per new share, opens on February 3 and closes on February 14, 2025.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.

NuEnergy has finalized the Gas Sales and Purchase Agreement for its Tanjung Enim project and is advancing drilling preparations, marking a key step toward production and revenue generation.

Australian Foundation Investment Company Limited (AFIC) has announced a fully franked dividend of AUD 0.12 per share for the half-year ending December 2024, accompanied by Dividend Reinvestment and Bonus Security Plans.

Etherstack has secured a $1.2 million contract with AT&T to supply wireless network equipment, reinforcing its role in mission-critical communications and promising revenue growth this financial year.

Terrain Minerals has raised $450,000 through a strategic placement to fund high-impact drilling at its Smokebush Gold and Lort River Nickel/Copper projects, aiming to unlock significant mineral potential in Western Australia.

Viridis Mining and Minerals has announced a substantial upgrade to its Colossus Ionic Adsorption Clay Rare Earth Element Project, reporting a 140% increase in its JORC-compliant Mineral Resource Estimate. This positions Colossus as the largest and highest-grade IAC rare earth resource globally, with significant implications for the rare earth sector.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

The GPT Group has forged a strategic partnership for Rouse Hill Town Centre and increased its ownership in Highpoint Shopping Centre to 25%, unlocking $176 million in net proceeds to reduce gearing and fuel future investments.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.